Výsledky vyhledávání

Akademický článek

Optimising primary molecular profiling in non-small cell lung cancer.

Publikováno v: PLoS ONE, Vol 19, Iss 7, p e0290939 (2024)

IntroductionMolecular profiling of NSCLC is essential for optimising treatment decisions, but often incomplete. We assessed the efficacy of protocolised molecular profiling in the current standard-of-care (SoC) in a prospective observational study in

Externí odkaz: https://doaj.org/article/87e38726aa1c4be1b473231f9e459023

Zobrazit plný text záznamu

Plný text ve formátu HTML

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Autor: F. Terhegggen, G. P. Bootsma, Hans M. Westgeest, Jessica S.W. Borgers, Daphne W. Dumoulin, M. Cloos, J. W. G. van Putten, John B. A. G. Haanen, C. J. van Loenhout, W. K. de Jong, I. Houtenbos, G. A. Cirkel, Otto Visser, J. C. Drooger, R. A.W. van de Wetering, T. J.N. Hiltermann, B. van den Borne, F. S. van der Meer, V. J.A.A. Nuij, Esther Oomen-de Hoop, C. H. van der Leest, Hanneke W. M. van Laarhoven, A. Becker-Commissaris, S. C.van t. Westeinde, A. P. Hamberg, L. van Leeuwen, A. S.R. van Lindert, B. W. Bouter, Rutger H. T. Koornstra, F. J. Borm, C. H. Rikers, E. A. Kastelijn, B. M.J. Scholtes, Y. Klaver, E. J.M. Siemerink, D. M. van Diepen, A. L. Peerdeman, Mieke J. Aarts, K. H. Herbschleb, V. E.M. van den Boogaart, Karijn P M Suijkerbuijk, G. Douma, S. D. Bakker, Karlijn de Joode, A. J. Staal, M. P.L. Bard, J. A. Stigt, C. C.M. Pitz, L. J. C. van Warmerdam, E. Looysen, Laurens V. Beerepoot, P. Brocken, C. R. van Rooijen, N. J.M. Claessens, Haiko J. Bloemendal, A.J. van de Wouw, Astrid A M van der Veldt, E. Citgez, Franchette W P J van den Berkmortel, M. Youssef, E. J. Geraedts, Nico G.J. van Diemen, G. L. Veurink, E. J. Libourel, N. P. Barlo, Elisabeth G.E. de Vries, J.W.B. de Groot, Anne-Marie C. Dingemans, W. H. van Geffen, G. J.M. Herder, Pim G N J Mutsaers, L. Strobbe, Jolien Tol, R. Heller, L. M. Faber, B. Franken, Lizza E.L. Hendriks, Mathilde Jalving, O. C.J. Schuurbiers-Siebers, B. C.M. Haberkorn, M. A. Tiemessen, M. Slingerland

Publikováno v: European Journal of Cancer
European Journal of Cancer, 141, pp. 171-184
European Journal of Cancer, 141, 171-184
European Journal of Cancer, 141, 171-184. Elsevier Limited
European Journal of Cancer, 141, 171-184. ELSEVIER SCI LTD
European Journal of Cancer, 141, 171-184. Elsevier Ltd.

Aim of the study Patients with cancer might have an increased risk for severe outcome of coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse outcome of COVID-19, a nationwide registry was developed for patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab8641c47fce20aca6e3c9edc471009
http://www.scopus.com/inward/record.url?scp=85095410706&partnerID=8YFLogxK

Zobrazit plný text záznamu

Predicting prognosis in idiopathic pulmonary fibrosis

Autor: N P, Barlo, C H M, van Moorsel, J M M, van den Bosch, J C, Grutters

Publikováno v: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 27(2)

Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. In 2002, the ATS/ERS published new criteria that significantly changed the definition of IPF, resulting in a more homogeneous group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2622ba1af25e6d9f2fccfd621ba33b19
https://pubmed.ncbi.nlm.nih.gov/21319590

Zobrazit plný text záznamu

Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis

Autor: N P, Barlo, C H M, van Moorsel, H J T, Ruven, P, Zanen, J M M, van den Bosch, J C, Grutters

Publikováno v: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 26(2)

Idiopathic pulmonary fibrosis is a progressive interstitial lung disease with a high mortality rate. As lung transplantation is the only therapeutic option, it is important to predict survival.This study evaluates the clinical value of surfactant pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0fe459d928ba140086d56c722815970f
https://pubmed.ncbi.nlm.nih.gov/20560296

Zobrazit plný text záznamu

Therapeutic strategies for epidemic Kaposi's sarcoma

Autor: N P Barlo, M Aldenhoven, C J G Sanders

Publikováno v: International journal of STDAIDS. 17(9)

Kaposi's sarcoma (KS) remains the most commonly diagnosed malignancy in HIV-infected patients, and is one of the AIDS-defining diagnoses. Several different therapeutic options are available, but the optimal therapy is still unclear. The incidence of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98dcc59e4d9195dd66bd11129e734e43
https://pubmed.ncbi.nlm.nih.gov/16942647

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání